Postprandial blood glucose as a risk factor for cardiovascular disease in Type II diabetes: The epidemiological evidence

Diabetologia

Volumn 44, Issue 12, 2001, Pages 2107-2114

  Bonora, E ^a   Muggeo, M ^a  

^a MAGGIORE HOSPITAL   (Italy)

Author keywords

Cardiovascular disease; Fasting glucose; HbA1c; Postprandial glucose; Type II diabetes

Indexed keywords

GLUCOSE;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIABETES CONTROL; DISEASE SEVERITY; EPIDEMIOLOGICAL DATA; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INCIDENCE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; POSTPRANDIAL STATE; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; EPIDEMIOLOGIC METHODS; HUMANS; POSTPRANDIAL PERIOD; RISK FACTORS;

EID: 0035675342     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250100020     Document Type: Review

References (70)

1. The Verona diabetes study: A population-based survey on known diabetes mellitus prevalence and 5-year all-cause mortality
2. Global burden of diabetes, 1995-2025. Prevalence, numerical estimates, and projections
3. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in the U.S. population aged 20-74 years
4. Diabetes incidence in Pima Indians: Contribution of obesity and parental diabetes
5. Economic consequences of diabetes mellitus in the U.S. in 1997
6. Hyperglycemia and cardiovascular disease in type 2 diabetes
7. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the multiple risk factor intervention trial
8. A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women
9. Cause-specific mortality in type 2 diabetes
10. Plasma lipids and lipoproteins at diagnosis of NIDDM by age and sex
11. Hypertension in Diabetes Study (HDS). I. Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications
12. Atherogenesis in diabetes
13. Standards of care for patients with diabetes mellitus (Position Statement)
14. Glycemic control and cardiovascualar diseases in type 2 diabetes mellitus. Beyond fasting glycemia and glycosylated hemoglobin (Consensus Document)
15. Variation of postprandial plasma glucose, palatability and symptoms associated with a standardized mixed test meal versus 75 g oral glucose
16. Intraindividual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in general Caucasians population: The Hoorn Study
17. Coronary heart disease risk and impaired glucose tolerance: The Whitehall Study
18. Hypertriglyceridemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study
19. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: Results from two population studies in Finland
20. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study
21. Cardiovascular disease in older adults with glucose disorders: Comparison of the American Diabetes Association criteria for diabetes mellitus with WHO criteria
22. Impaired glucose tolerance, Type II diabetes mellitus and carotid artherosclerosis. Prospective results from the Bruneck Study
23. Carotid artery stenosis is related to blood glucose level in an elderly Caucasian population: The Hoorn Study
24. Distribution. And correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study
25. Asymptomatic hyperglycemia is associated with increased intimal plus medial thickness of the carotid artery
26. Report of the expert committee on the diagnosis and classification of diabetes mellitus
27. Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data
28. Is fasting glucose sufficient to define diabetes? Epidemiological data from 20 European studies
29. Comparison of the fasting and the 2-h glucose criteria for diabetes in different Asian cohorts
30. Comparison of tests for glycated hemoglobin and fasting and 2-hour plasma glucose concentrations as diagnostic methods for diabetes
31. Complications in newly diagnosed type 2 diabetic patients and their association with different clinical and biochemical risk factors
32. Accelerated complications in type 2 diabetes mellitus: The need for greater awareness and earlier detection
33. Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes?
34. Glucose intolerance and 23-year risk of coronary heart disease and total mortality
35. Diabetes, asymptomatic hyperglycemia, and 22-year mortality in black and white men: The Chicago Heart Association Detection Project in Industry Study
36. Isolated postchallange hyperglycemia and the risk of fatal cardiovascular disease in older women and men. The Rancho Bernardo Study
37. Is there a glycemic threshold for mortality risk?
38. Isolated post-challenge hyperglycemia confirmed as a risk factor for mortality
39. Hyperglycemia is associated with all-cause and cardiovascular mortality in the Hoorn population: The Hoorn Study
40. Glucose tolerance and mortality: Comparison of WHO and American Diabetes Association diagnostic criteria
41. Impaired glucose tolerance and diabetes
42. Consequences of the new diagnostic criteria for diabetes in older men and women
43. Glucose tolerance and cardiovascular mortality. Comparison of fasting and 2-h diagnostic criteria
44. Postprandial plasma glucose is an independent risk factor for increased carotid intima-media thickness in non-diabetic individuals
45. Risk factors for myocardial infarction and death in newly detected NIDDM: The Diabetes Intervention Study, 11-year follow-up
46. Effect of glycemia on mortality in Pima Indians with type 2 diabetes
47. NIDDM and its metabolic control predict coronary heart disease in elderly subjects
48. Non-insulin-dependent diabetes and its metabolic control are important predictors of stroke in elderly subjects
49. Reduced fibrinogen survival in diabetes mellitus. A reversible phenomenon
50. Oxidative stress and diabetic vascular complications
51. Activation of human platelet protein kinase C-beta 2 in vivo in response to acute hyperglycemia
52. Vascular effects of acute hyperglycemia in humans are reversed by L-arginine: Evidence for reduced availability of nitric oxide during hyperglycemia
53. Acute hyperglycemia attenuates endothelium-dependent vasodilatation in humans in vivo
54. The emerging role of postprandial hyperglycemic spikes in the pathogenesis of diabetic complications
55. Endothelium-dependent vasodilatation is impaired in both microcirculation and macrocirculation during acute hyperglycemia
56. Role of oxidative stress in diabetic complications: A new perspective on an old paradigm
57. Circulating adhesion molecules in humans: Role of hyperglyaemia and hyperinsulinemia
58. The postprandial state and cardiovascular disease: Relevance to diabetes mellitus
59. Effects of hypoglycaemic agents on vascular complications in patients with adult-onset diabetes. VIII. Evaluation of insulin therapy. Final report
60. Cardiovascular events and correlates in the Veteran Affairs Diabetes Feasibility Trial. Veterans Affairs Cooperative Study on glycemic control and complications in type 2 diabetes (VA CSDM)
61. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
62. Effect of intensive blood glucose control with metformin on complications in overweight patients with type 2 diabetes. (UKPDS 34)
63. Postprandial blood glucose. Consensus statement
64. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
65. Long term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients
66. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus
67. A desktop guide to type 2 diabetes mellitus
68. Nateglinide alone and in combination with metformin inproves glycemic control by reducing mealtime glucose levels in type 2 diabetes
69. A 1-year multicenter randomized double-blind comparison of repaglinide and glyburide for the treatment of type 2 diabetes